Terms: = Cervical cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Diagnosis
4 results:
1. Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
Brebi P; Ili CG; Andana A; Menzel D; Lopez J; Guzman P; Melo A; Buchegger K; Roa JC
BMC Cancer; 2017 Aug; 17(1):518. PubMed ID: 28774281
[TBL] [Abstract] [Full Text] [Related]
2. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
[TBL] [Abstract] [Full Text] [Related]
3. [Semi-quantitative detection of HPV L1 capsid protein in exfoliative cytological examination facilitates the differential diagnosis of cervical lesions].
Xu X; Yang J; Lin N; Yang G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1194-7. PubMed ID: 25374086
[TBL] [Abstract] [Full Text] [Related]
4. Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population.
Nadpara PA; Madhavan SS; Khanna R; Smith M; Miller LA
Popul Health Manag; 2012 Dec; 15(6):362-71. PubMed ID: 22788858
[TBL] [Abstract] [Full Text] [Related]
